Thalidomide ameliorates portal hypertension via nitric oxide synthase independent reduced systolic blood pressure

AIM: Portal hypertension is a common complication of liver cirrhosis and significantly increases mortality and morbidity. Previous reports have suggested that the compound thalidomide attenuates portal hypertension (PHT). However, the mechanism for this action is not fully elucidated. One hypothesis...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:World J Gastroenterol
Prif Awduron: Theodorakis, Nicholas G, Wang, Yining N, Korshunov, Vyacheslav A, Maluccio, Mary A, Skill, Nicholas J
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Baishideng Publishing Group Inc 2015
Pynciau:
Basic Study
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4394073/
https://ncbi.nlm.nih.gov/pubmed/25892862
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i14.4126
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg